Elizabeth Kathleen Neumann

Elizabeth Kathleen Neumann

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elizabeth Kathleen Neumann has a total of 238 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • High-Throughput Mass Spectrometry Imaging of Single Human Hair Strands

    by Joanna E. Spurgeon, Phillip Enad, Kayle J. Bender, Marjan Dolatmoradi, Elizabeth K. Neumann, Manish Arora

    Human hair provides a stable, noninvasive matrix for longitudinal chemical analysis but remains under-utilized because of challenges in sample preparation, reproducibility, and throughput. Here, we present an automated, high-throughput platform for mass spectrometry imaging analysis of single human hair strands. This workflow integrates robotic longitudinal sectioning with custom-designed microscope slides to enable consistent sample preparation with minimal user intervention. The method achieves 95% success rate of sectioning, and strong interlaboratory concordance. We demonstrate spatial mapping of endogenous lipids, metabolites, environmental contaminants, and pharmaceuticals across hair substructures, including the cortex and medulla. The platform enables temporal chemical profiling along the hair shaft and supports detection of both incorporated and exogenous compounds and establishes a scalable framework for biomarker discovery and forensic applications.

  • MALDI-TOF Mass Spectrometry Imaging for Spatially Resolved Degradation Profiling of Solid Formulations

    by Rekha Thomas, Karina A. Vargas, Zhenqi Shi, Jason Gruenhagen, Christopher M. Crittenden, Elizabeth K. Neumann

    Understanding the stability of the active pharmaceutical ingredient (API) and drug−excipient interactions is critical for ensuring the efficacy and shelf life of pharmaceutical formulations. This study applies matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) to investigate two-dimensional (2D) and three-dimensional (3D) spatial profiling of degradants in Losartan potassium tablets that are subjected to temperature- and humidity-induced stress conditions. This approach allows for in situ visualization of API degradation and excipient compatibility within solid dosage forms. Upon stress, Losartan tablets formed dimeric and trimeric species as major degradation products. Spatial mapping revealed a gradual growth of these degradants from the control (T0) through four weeks of stress. Ion images showed distinct heterogeneity in the formation of dimer and trimer species across the tablet depth and plane; however, no preferential pattern was observed at the tablet periphery. The random distribution of degradants suggests that alongside humidity, localized microenvironments drive the degradation process. MALDI-MSI demonstrates strong potential as a high-throughput and sensitive alternative to traditional liquid chromatography-based procedures for early-stage formulation screening. Furthermore, this work suggests that when integrated with orthogonal techniques to coregister excipient domains, MALDI-MSI can serve as an emerging tool to uniquely characterize drug−excipient interactions during early-stage drug development. This provides spatially resolved insight that enhances accelerated stability assessment programs and streamline the selection of compatible excipients.

  • Open Access

    Metabolic Niches: MALDI Imaging Reveals Lipidomic Heterogeneity in the Human Heart

    by Kayla M. Osumi, Evan P. Kransdorf, Daniel Manzoor, Anja Karlstaedt, Elizabeth K. Neumann

    The human heart is characterized by aberrant lipid accumulation and remodeling during periods of stress and disease, yet spatially resolved lipidomic profiling of the human heart remains unreported. Here, we employ matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) to map lipid distributions across five anatomical regions of healthy human donor hearts (left and right atrium, left and right ventricle, and interventricular septum). Cryosections of donor hearts from healthy subjects were thaw-mounted onto indium tin oxide slides, coated with 2,5-dihydroxyacetophenone, and analyzed on a Bruker timsTOF fleX mass spectrometer in positive and negative ionization modes (m/z 50–1850; 20 μm raster spacing). Serial sections were stained with hematoxylin and eosin to enable histological coregistration with lipid distributions. We identified 150 unique lipid species across four glycerophospholipid classes, including phosphatidylcholine (PC), phosphatidylglycerol (PG), phosphatidylethanolamine (PE), and phosphatidylserine (PS), with abundances and spatial distributions differing significantly between regions. H&E coregistration further resolved epicardial and myocardial compartments, enabling tissue-specific lipid mapping. These findings establish the first spatially resolved lipidomic profiles of the human heart and provide a framework for identifying region-specific lipid biomarkers of cardiovascular disease.

  • Open Access

    Improving detection of low-abundant pharmaceuticals and neurotransmitters via quadrupole isolation in MALDI mass spectrometry imaging

    by Karina A. Vargas, Sarah Diez, Michael Becker, Elizabeth K. Neumann

    Matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) is a powerful tool for mapping the spatial distribution of pharmaceuticals and metabolites in tissue. However, its effectiveness in the low-mass range (< 400 m/z) is impacted by matrix interference and ion suppression, reducing signal-to-noise (S/N) ratios. To address this challenge, we assessed a targeted quadrupole isolation strategy using a MALDI q-TOF mass spectrometer. This approach selectively isolates narrow windows around individual analytes m/z to reduce background noise and enhance S/N, therefore generating a smaller selective ion packet to the TOF analyzer. We applied this method to detect acetaminophen, paracetamol sulfate, caffeine, paraxanthine, as well as dopamine and its metabolites (HVA, 3-MT, and DOPAC) within murine liver and brain tissue sections, respectively. We utilized a range of isolation windows (e.g., 1, 5, 10, 20, 100 m/z) around each target m/z value. This dynamic isolation significantly decreased chemical background without fragmenting the target ions. As a result, we achieved precise spatial localization of parent drugs and their metabolites. Compared to untargeted acquisition, this method improved S/N by over 50% for all analytes within ≤10 m/z isolation ranges, while preserving tissue morphology. This targeted isolation approach extends the capabilities of MALDI MSI and offers a robust and scalable solution for analyzing low-mass xenobiotics and metabolites in situ.

  • Open Access

    MOSDAP MxIF v1

    by Siena Austin, Maya Brewer, Liz McDonough, Yuantee Zhu, Elizabeth Neumann, Danielle Gutierrez, Jeff Spraggins, Mark De Caestecker, Melissa Farrow

    Scope: To complete multiplex immunofluorescence on fresh frozen human tissue. Expected Outcome: Tissue sections that have been tagged with antibodies for imaging microscopy.

  • Open Access

    Metabolic niches: MALDI imaging reveals lipidomic heterogeneity in the human heart

    by Kayla Osumi, Evan Kransdorf, Anja Karlstaedt, Elizabeth K Neumann

    We investigated the spatial organization and heterogeneity of lipids across the healthy human heart to establish a regional metabolic framework. Using untargeted spatially resolved lipidomics with matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI), we identified distinct regional lipidomic signatures in cardiac regions. Our study challenges the assumption of metabolic uniformity and providing a framework for spatially targeted therapies and improved biomarker interpretation.

  • Open Access

    Spatial Lipidomic Profiling of Kidney Functional Units in SIV-Infected and ART-Treated Rhesus Macaques

    by Kyle A. Vanderschoot, Cory J. White, Kelli A. Steineman, Christopher M. De Caro, Dionna W. Williams, Elizabeth K. Neumann

  • Open Access

    Roles of FXR in Lipid Biochemistry within Hepatocellular Carcinoma Using MALDI MSI

    by Kayle J. Bender, Ying Hu, Blanca R. Teodoro, Chuo Ying Zhai, Yu-Jui Yvonne Wan, Elizabeth K. Neumann

    Hepatocellular carcinoma (HCC) is a common type of cancer with a high mortality rate, which is affected by the farnesoid X receptor (FXR) in the liver. FXR is a ligand-activated nuclear receptor involved in lipid metabolism and homeostasis. Matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) enables spatially resolved molecular analysis and is particularly suited to profiling lipid distributions within tissues. In this study, MALDI MSI was employed to investigate alterations in liver lipid composition associated with HCC and FXR expression with a focus on phosphatidylcholine (PC) species. Distinct spatial and compositional differences in PC lipids were observed between HCC and nontumorous regions. Furthermore, we hypothesize a role of PC(38:4) in HCC based on cell culture experiments in which Hep3B cells were incubated in the presence of PC(38:4).

  • Open Access

    Spatial Detection of Microsphere Polystyrene Plastics and Molecular Remodeling within a Full‐Body Mouse with MALDI Trapped Ion Mobility Mass Spectrometry Imaging

    by Karina A. Vargas, Amy L. Parkhurst, Ming‐Fo Hsu, Christopher Hou, Fawaz G. Haj, Elizabeth K. Neumann

    Polystyrene (PS), a widely used synthetic polymer, breaks into micro‐ and nanoscale particles that can enter the body and accumulate in tissues. Conventional methods provide bulk chemical information, but lack spatial and metabolic context. Here, we use matrix‐assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) with trapped ion mobility spectrometry (TIMS) to localize PS across whole‐body murine sections and individual organs, allowing differentiation of PS chain lengths and associated metabolic shifts. Oral PS exposure produced clear organ‐specific lipid remodeling. In the stomach, increases in phosphatidylcholine (PC(30:2)), phosphatidic acid (PA(36:1)), and sphingomyelin (SM(34:1; O 2 )) suggest epithelial stress and barrier disruption. In the liver, PC(32:1) decreased, and higher PC(30:2) and PA(36:2) indicate impaired lipid export alongside compensatory adjustments to maintain membrane stability, with potential effects on systemic lipid balance. In the heart, reductions in SM(32:1; O 2 ), ether‐linked phosphatidic acid (PA(O‐34:1)), and hexosylceramide (HexCer(30:1; O 2 )) reflect disrupted sphingolipid and ether‐linked lipid species metabolism and altered lipid transport. Together, these findings reveal dynamic, tissue‐specific lipid responses to PS exposure. This study shows that MALDI TIMS MSI provides high‐resolution, label‐free mapping of PS and its metabolic footprint and can be extended to other low‐abundance synthetic compounds.

  • Open Access

    Spatial Detection of Microsphere Polystyrene Plastics and Molecular Remodeling within a Full‐Body Mouse with MALDI Trapped Ion Mobility Mass Spectrometry Imaging

    by Karina A. Vargas, Amy L. Parkhurst, Ming‐Fo Hsu, Christopher Hou, Fawaz G. Haj, Elizabeth K. Neumann

    Polystyrene (PS), a widely used synthetic polymer, breaks into micro‐ and nanoscale particles that can enter the body and accumulate in tissues. Conventional methods provide bulk chemical information, but lack spatial and metabolic context. Here, we use matrix‐assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) with trapped ion mobility spectrometry (TIMS) to localize PS across whole‐body murine sections and individual organs, allowing differentiation of PS chain lengths and associated metabolic shifts. Oral PS exposure produced clear organ‐specific lipid remodeling. In the stomach, increases in phosphatidylcholine (PC(30:2)), phosphatidic acid (PA(36:1)), and sphingomyelin (SM(34:1; O 2 )) suggest epithelial stress and barrier disruption. In the liver, PC(32:1) decreased, and higher PC(30:2) and PA(36:2) indicate impaired lipid export alongside compensatory adjustments to maintain membrane stability, with potential effects on systemic lipid balance. In the heart, reductions in SM(32:1; O 2 ), ether‐linked phosphatidic acid (PA(O‐34:1)), and hexosylceramide (HexCer(30:1; O 2 )) reflect disrupted sphingolipid and ether‐linked lipid species metabolism and altered lipid transport. Together, these findings reveal dynamic, tissue‐specific lipid responses to PS exposure. This study shows that MALDI TIMS MSI provides high‐resolution, label‐free mapping of PS and its metabolic footprint and can be extended to other low‐abundance synthetic compounds.